表紙
市場調査レポート

CountryFocus:サウジアラビアの医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

発行 GlobalData 商品コード 307124
出版日 ページ情報 英文 238 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
CountryFocus:サウジアラビアの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia
出版日: 2016年07月01日 ページ情報: 英文 238 Pages
概要

サウジアラビアの総人口は2013年には2990万人、年間増加率は約3%と推計されています。2012年時点で、人口の32.1%は外国人(主に南アジア諸国や他のイスラム諸国からの移民)が占めています。2020年までの年平均(CAGR)人口増加率は3%、同年の総人口は3680万人に達する見込みです。サウジアラビアの医薬品市場は、2013年には40億米ドルに達し、さらに2020年には約59億米ドルにまで拡大する(その間の年平均成長率(CAGR)は5.8%)、と予測されています。市場の大半は国外から輸入されたOTC医薬品や特許薬が占めています。

当レポートでは、サウジアラビアの医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、サウジアラビア経済・社会に関するマクロ的指標(医療インフラなど)、今後の市場機会と課題といった情報を取りまとめて、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野
    • 主要企業
  • 医療機器市場
    • 市場概況
    • 上位5分野の概要
    • 診断市場
    • 主要企業
  • 市場の促進・阻害要因
    • 促進要因
    • 阻害要因

第4章 市場へのアクセス

  • 医療費償還・保険料支払者の状況
    • 医療制度の概要
    • 医療費償還の過程
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 医療サービスの価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 医薬品の販売認証過程
    • 医療機器の新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出入の認証過程
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 公共/民間部門のシェア
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0064CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Saudi Arabia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, Saudi Arabia's population was approximately at 31.5 million. The government of Saudi Arabia has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Saudi pharmaceutical market is one of the largest in the Middle East and the largest of the Gulf Co-operation Council (GCC) members, estimated to be worth $4.5 billion in 2015 and expected to reach $6 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 7.4% over the 2008-2020 period. The medical device market was valued at $1.3 billion in 2008 and is expected to reach approximately $1.8 billion by 2020, at a projected CAGR of 4.6%.

These positive trends can primarily be attributed to -

  • An increasing elderly population in Saudi Arabia, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Saudi Arabia, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Pfizer, Novartis, SPIMACO, Tabuk Pharmaceuticals) and the medical device market (Siemens Healthcare, GE Healthcare, Roche, Philips Healthcare, Abbott Laboratories)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Saudi Arabian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Saudi Arabian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Saudi Arabian healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of the Pharmaceutical and Medical Device Market

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Major Diseases
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of the Top Five Segments
    • 3.2.3. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare system
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Price Trends in the Healthcare Sector
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Fiscal Surplus/Deficit
    • 5.3.9. General Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Share of Public and Private Sector
  • 5.7. Trade Associations
    • 5.7.1. Saudi Pharmaceutical Society
    • 5.7.2. Saudi Dental Society
    • 5.7.3. Gulf Pharmaceutical Industries Association
    • 5.7.4. Middle East Medical Devices and Diagnostics Trade Association
    • 5.7.5. Middle East Generic Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Saudi Arabia, Revenue ($bn), 2008-2015
  • Table 2: Pharmaceutical Market, Saudi Arabia, Revenue ($bn), 2016-2020
  • Table 3: Pharmaceutical Market, Saudi Arabia, Exports and Imports ($bn), 2008-2014
  • Table 4: Pharmaceutical Market, Saudi Arabia, Generic Market Revenue ($m), 2008-2014
  • Table 5: Pharmaceutical Market, Saudi Arabia, OTC Market Revenue ($m), 2008-2014
  • Table 6: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015
  • Table 7: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016
  • Table 8: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 9: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
  • Table 10: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 11: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018
  • Table 12: SPIMACO, Major Products, 2015
  • Table 13: Tabuk, Major Products, 2015
  • Table 14: Medical Device Market, Saudi Arabia, Revenue ($bn), 2008-2015
  • Table 15: Medical Device Market, Saudi Arabia, Revenue ($bn), 2016-2020
  • Table 16: Medical Device Market, Saudi Arabia, Revenue ($m) and Share (%) of Major Segments, 2015
  • Table 17: Medical Device Market, Saudi Arabia, In Vitro Diagnostic Revenue ($m), 2008-2015
  • Table 18: Medical Device Market, Saudi Arabia, Diagnostic Imaging Revenue ($m), 2008-2015
  • Table 19: Medical Device Market, Saudi Arabia, Sales Trends for Major Diagnostic Imaging Players (%), 2011
  • Table 20: Medical Device Market, Saudi Arabia, Ophthalmic Device Revenue ($m), 2008-2015
  • Table 21: Medical Device Market, Saudi Arabia, Sales Trends for Major Ophthalmic Device Players, 2012
  • Table 22: Medical Device Market, Saudi Arabia, Cardiovascular Device Revenue ($m), 2008-2015
  • Table 23: Medical Device Market, Saudi Arabia, Sales Trends for Major Cardiovascular Device Players, 2011
  • Table 24: Medical Device Market, Saudi Arabia, Nephrology and Urology Device Revenue ($m), 2008-2015
  • Table 25: Medical Device Market, Saudi Arabia, Sales Trends for Major Nephrology and Urology Device Players, 2012
  • Table 26: Medical Device Market, Saudi Arabia, Revenue ($m) and Share (%) of Major Players, 2015
  • Table 27: Siemens Healthcare, Global, Major Products, 2015
  • Table 28: Roche, Global, Major Products, 2016
  • Table 29: Medical Device Market, Roche, Global, Late-stage Pipeline, 2016
  • Table 30: Philips Healthcare, Global, Major Products, 2016
  • Table 31: Abbott, Global, Major Products, 2016
  • Table 32: Healthcare Spending, Saudi Arabia, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
  • Table 33: Economic Indicators, Saudi Arabia, Gross Domestic Product per Capita ($), 2008-2015
  • Table 34: Economic Indicators, Saudi Arabia, Gross Domestic Product per Capita ($), 2016-2020
  • Table 35: Economic Indicators, Saudi Arabia, Gross Domestic Product Annual Growth (%), 2008-2015
  • Table 36: Economic Indicators, Saudi Arabia, Gross Domestic Product Annual Growth (%), 2016-2020
  • Table 37: Economic Indicators, Saudi Arabia, Gross National Income per Capita ($), 2008-2015
  • Table 38: Economic Indicators, Saudi Arabia, Average Consumer Price Index, 2008-2015
  • Table 39: Economic Indicators, Saudi Arabia, Average Consumer Price Index, 2016-2020
  • Table 40: Economic Indicators, Saudi Arabia, Consumer Price Annual Change (%), 2008-2015
  • Table 41: Economic Indicators, Saudi Arabia, Currency Exchange Rate (SAR/$), 2008-2015
  • Table 42: Economic Indicators, Saudi Arabia, Foreign Direct Investment ($bn), 2008-2014
  • Table 43: Economic Indicators, Saudi Arabia, Foreign Exchange Reserves ($bn), 2008-2014
  • Table 44: Economic Indicators, Saudi Arabia, Imports of Goods and Services ($bn), 2008-2014
  • Table 45: Economic Indicators, Saudi Arabia, Exports of Goods and Services ($bn), 2008-2014
  • Table 46: Economic Indicators, Saudi Arabia, Budget Surplus/Deficit ($bn), 2008-2014
  • Table 47: Economic Indicators, Saudi Arabia, General Government Gross Debt (% of GDP), 2008-2015
  • Table 48: Economic Indicators, Saudi Arabia, GDP of Major Industrial Sectors ($bn), 2014-2015
  • Table 49: Demographics, Saudi Arabia, Population (million), 2008-2015
  • Table 50: Demographics, Saudi Arabia, Population (million), 2016-2020
  • Table 51: Demographics, Saudi Arabia, Urban and Rural Population Share (%), 2008-2015
  • Table 52: Demographics, Saudi Arabia, Urban and Rural Population Share (%), 2016-2020
  • Table 53: Demographics, Saudi Arabia, Population Distribution by Age Group (%), 2008-2015
  • Table 54: Demographics, Saudi Arabia, Population Distribution by Age Group (%), 2016-2020
  • Table 55: Demographics, Saudi Arabia, Births (per 1,000 population), 2008-2014
  • Table 56: Demographics, Saudi Arabia, Mortality (per 1,000 population), 2008-2014
  • Table 57: Demographics, Saudi Arabia, Major Causes of Mortality, 2013
  • Table 58: Demographics, Saudi Arabia, Mortality Rate of Children under Five (per 1,000 live births), 2008-2014
  • Table 59: Demographics, Saudi Arabia, Immunization Rate (%), 2008-2014
  • Table 60: Demographics, Saudi Arabia, Major Causes of Male Mortality ('000), 2008
  • Table 61: Demographics, Saudi Arabia, Major Causes of Female Mortality ('000), 2008
  • Table 62: Demographics, Saudi Arabia, Gender Ratio (M/F), 2008-2014
  • Table 63: Demographics, Saudi Arabia, Life Expectancy at Birth (years), 2008-2014
  • Table 64: Demographics, Saudi Arabia, Life Expectancy at Birth (years), 2016-2020
  • Table 65: Demographics, Saudi Arabia, Student Enrollment by Level of Education (million), 2008-2014
  • Table 66: Demographics, Saudi Arabia, Unemployment Rate (%), 2008-2014
  • Table 67: Demographics, Saudi Arabia, Health Center Visits by Major Diseases (million), 2011
  • Table 68: Demographics, Saudi Arabia, DALYs by Major Diseases (per 1,000 population), 2009
  • Table 69: Healthcare Infrastructure, Saudi Arabia, Hospitals, 2008-2013
  • Table 70: Healthcare Infrastructure, Saudi Arabia, Hospitals by Type of Care, 2014
  • Table 71: Healthcare Infrastructure, Saudi Arabia, Primary Healthcare Centers, 2008-2014
  • Table 72: Healthcare Infrastructure, Saudi Arabia, Hospital Beds (per 10,000 population), 2008-2014
  • Table 73: Healthcare Infrastructure, Saudi Arabia, Doctors (per 10,000 population), 2008-2014
  • Table 74: Environmental Health, Saudi Arabia, CO2 Emissions (million tons), 2008-2014
  • Table 75: Environmental Health, Saudi Arabia, PM2.5 (µgm/m³), 2008-2014
  • Table 76: Healthcare Personnel, Saudi Arabia, Healthcare Personnel (per 10,000 population), 2008-2014
  • Table 77: Healthcare Expenditure, Saudi Arabia, Healthcare Expenditure (% of GDP), 2008-2014
  • Table 78: Healthcare Expenditure, Saudi Arabia, Public-Private Share (%), 2008-2014
  • Table 79: Major Healthcare Trade Fairs, Saudi Arabia, 2016

List of Figures

  • Figure 1: Pharmaceutical Market, Saudi Arabia, Revenue ($bn), 2008-2015
  • Figure 2: Pharmaceutical Market, Saudi Arabia, Revenue ($bn), 2016-2020
  • Figure 3: Pharmaceutical Market, Saudi Arabia, Exports and Imports ($bn), 2008-2014
  • Figure 4: Pharmaceutical Market, Saudi Arabia, Generic Market Revenue ($m), 2008-2014
  • Figure 5: Pharmaceutical Market, Saudi Arabia, OTC Market Revenue ($m), 2008-2014
  • Figure 6: Medical Device Market, Saudi Arabia, Revenue ($bn), 2008-2015
  • Figure 7: Medical Device Market, Saudi Arabia, Revenue ($bn), 2016-2020
  • Figure 8: Medical Device Market, Saudi Arabia, Revenue by Major Segment ($m), 2015
  • Figure 9: Medical Device Market, Saudi Arabia, In Vitro Diagnostic Revenue ($m), 2008-2015
  • Figure 10: Medical Device Market, Saudi Arabia, Diagnostic Imaging Revenue ($m), 2008-2015
  • Figure 11: Medical Device Market, Saudi Arabia, Sales Trends for Major Diagnostic Imaging Players (%), 2011
  • Figure 12: Medical Device Market, Saudi Arabia, Ophthalmic Device Revenue ($m), 2008-2015
  • Figure 13: Medical Device Market, Saudi Arabia, Sales Trends for Major Ophthalmic Device Players (%), 2012
  • Figure 14: Medical Device Market, Saudi Arabia, Cardiovascular Device Revenue ($m), 2008-2015
  • Figure 15: Medical Device Market, Saudi Arabia, Sales Trends for Major Cardiovascular Device Players (%), 2011
  • Figure 16: Medical Device Market, Saudi Arabia, Nephrology and Urology Device Revenue ($m), 2008-2015
  • Figure 17: Medical Device Market, Saudi Arabia, Sales Trends for Major Nephrology and Urology Device Players (%), 2012
  • Figure 18: Medical Device Market, Saudi Arabia, Revenue of Major Players ($m), 2015
  • Figure 19: Healthcare Market, Saudi Arabia, Drivers and Barriers, 2016
  • Figure 20: Healthcare Spending, Saudi Arabia, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
  • Figure 21: Healthcare System, Saudi Arabia, Saudi Food and Drug Authority Structure, 2016
  • Figure 22: Healthcare System, Saudi Arabia, Drug Licensing Approval Process, 2014
  • Figure 23: Healthcare System, Saudi Arabia, Drug Licensing - Market Authorization, 2014
  • Figure 24: Healthcare System, Saudi Arabia, Patent-Approval Process, 2016
  • Figure 25: Economic Indicators, Saudi Arabia, Gross Domestic Product per Capita ($), 2008-2015
  • Figure 26: Economic Indicators, Saudi Arabia, Gross Domestic Product per Capita ($), 2016-2020
  • Figure 27: Economic Indicators, Saudi Arabia, Gross Domestic Product Annual Growth (%), 2008-2015
  • Figure 28: Economic Indicators, Saudi Arabia, Gross Domestic Product Annual Growth (%), 2016-2020
  • Figure 29: Economic Indicators, Saudi Arabia, Gross National Income per Capita ($), 2008-2015
  • Figure 30: Economic Indicators, Saudi Arabia, Average Consumer Price Index, 2008-2015
  • Figure 31: Economic Indicators, Saudi Arabia, Average Consumer Price Index, 2016-2020
  • Figure 32: Economic Indicators, Saudi Arabia, Consumer Price Annual Change (%), 2008-2015
  • Figure 33: Economic Indicators, Saudi Arabia, Currency Exchange Rate (SAR/$), 2008-2015
  • Figure 34: Economic Indicators, Saudi Arabia, Foreign Direct Investment ($bn), 2008-2014
  • Figure 35: Economic Indicators, Saudi Arabia, Foreign Exchange Reserves ($bn), 2008-2014
  • Figure 36: Economic Indicators, Saudi Arabia, Imports of Goods and Services ($bn), 2008-2014
  • Figure 37: Economic Indicators, Saudi Arabia, Exports of Goods and Services ($bn), 2008-2014
  • Figure 38: Economic Indicators, Saudi Arabia, Budget Surplus/Deficit ($bn), 2008-2014
  • Figure 39: Economic Indicators, Saudi Arabia, General Government Gross Debt (% of GDP), 2008-2015
  • Figure 40: Economic Indicators, Saudi Arabia, GDP of Major Industrial Sectors ($bn), 2014-2015
  • Figure 41: Demographics, Saudi Arabia, Population (million), 2008-2015
  • Figure 42: Demographics, Saudi Arabia, Population (million), 2016-2020
  • Figure 43: Demographics, Saudi Arabia, Urban and Rural Population Share (%), 2008-2015
  • Figure 44: Demographics, Saudi Arabia, Urban and Rural Population Share (%), 2016-2020
  • Figure 45: Demographics, Saudi Arabia, Population Distribution by Age Group (%), 2008-2015
  • Figure 46: Demographics, Saudi Arabia, Population Distribution by Age Group (%), 2016-2020
  • Figure 47: Demographics, Saudi Arabia, Births (per 1,000 population), 2008-2014
  • Figure 48: Demographics, Saudi Arabia, Mortality (per 1,000 population), 2008-2014
  • Figure 49: Demographics, Saudi Arabia, Major Causes of Mortality, 2013
  • Figure 50: Demographics, Saudi Arabia, Mortality Rate of Children under Five (per 1,000 live births), 2008-2014
  • Figure 51: Demographics, Saudi Arabia, Immunization Rate (%), 2008-2014
  • Figure 52: Demographics, Saudi Arabia, Major Causes of Male Mortality ('000), 2008
  • Figure 53: Demographics, Saudi Arabia, Major Causes of Female Mortality ('000), 2008
  • Figure 54: Demographics, Saudi Arabia, Gender Ratio (M/F), 2008-2014
  • Figure 55: Demographics, Saudi Arabia, Life Expectancy at Birth (years), 2008-2014
  • Figure 56: Demographics, Saudi Arabia, Life Expectancy at Birth (years), 2016-2020
  • Figure 57: Demographics, Saudi Arabia, Student Enrollment by Level of Education (million), 2008-2014
  • Figure 58: Demographics, Saudi Arabia, Unemployment Rate (%), 2008-2014
  • Figure 59: Demographics, Saudi Arabia, Health Center Visits by Major Diseases (million), 2011
  • Figure 60: Demographics, Saudi Arabia, DALYs by Major Diseases (per 1,000 population), 2009
  • Figure 61: Healthcare Infrastructure, Saudi Arabia, Hospitals, 2008-2014
  • Figure 62: Healthcare Infrastructure, Saudi Arabia, Hospitals by Type of Care, 2014
  • Figure 63: Healthcare Infrastructure, Saudi Arabia, Primary Healthcare Centers, 2008-2014
  • Figure 64: Healthcare Infrastructure, Saudi Arabia, Hospital Beds (per 10,000 population), 2008-2014
  • Figure 65: Healthcare Infrastructure, Saudi Arabia, Doctors (per 10,000 population), 2008-2014
  • Figure 66: Environmental Health, Saudi Arabia, CO2 Emissions (million metric tons), 2008-2014
  • Figure 67: Environmental Health, Saudi Arabia, PM2.5 (µgm/m³), 2008-2014
  • Figure 68: Healthcare Personnel, Saudi Arabia, Healthcare Personnel (per 10,000 population), 2008-2014
  • Figure 69: Healthcare Expenditure, Saudi Arabia, Healthcare Expenditure (% of GDP), 2008-2014
  • Figure 70: Healthcare Expenditure, Saudi Arabia, Public-Private Share (%), 2008-2014
  • Figure 71: Healthcare Market, Saudi Arabia, Opportunities and Challenges, 2016
Back to Top